Antioxidant and Hypolipidemic Activities of Cinnamic Acid Derivatives
- PMID: 37764507
- PMCID: PMC10535275
- DOI: 10.3390/molecules28186732
Antioxidant and Hypolipidemic Activities of Cinnamic Acid Derivatives
Abstract
Oxidative stress and hyperlipidemia are important factors for the initiation and progression of various cell degenerative pathological conditions, including cardiovascular and neurological diseases. A series of cinnamic acid-derived acids, such as ferulic acid, sinapic acid, 3,4-dimethoxycinnamic acid, p-coumaric acid, and (E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)acrylic acid, were esterified or amidated with various moieties, bearing different biological activities, and evaluated. The antioxidant and radical scavenging abilities of the compounds via inhibition of rat hepatic microsomal membrane lipid peroxidation, as well as their interaction with the stable radical 2,2-diphenyl-1-picrylhydrazyl (DPPH), were assessed. Further, their hypolipidemic activity in vivo was tested. The majority of the obtained compounds demonstrated considerable radical scavenging and antioxidant action, with a parallel decrease in Triton-induced hyperlipidemia in rats. The (E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)acrylic acid derivative with morpholine and 4-methylpiperidine (compounds 4 and 13, respectively) significantly decreased triglycerides and total cholesterol in the plasma of hyperlipidemic rats, with an antioxidant capacity similar to that of the antioxidant Trolox. The compounds were designed to exhibit antioxidant and hypolipidemic pharmacological actions, and this succeeded for the majority of them. Thus, such agents may be of interest in conditions and diseases implicating oxidative stress and dyslipidemia.
Keywords: 3-phenylacrylic acid; antioxidants; cinnamic acid derivatives; hyperlipidemia; hypolipidemic agents; morpholine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Ferulic, Sinapic, 3,4-Dimethoxycinnamic Acid and Indomethacin Derivatives with Antioxidant, Anti-Inflammatory and Hypolipidemic Functionality.Antioxidants (Basel). 2023 Jul 17;12(7):1436. doi: 10.3390/antiox12071436. Antioxidants (Basel). 2023. PMID: 37507974 Free PMC article.
-
Tyrosine and proline conjugated trolox, hydroxy-cinnnamic acid and diclofenac hybrids as strong hypolipidemic and anti-inflammatory agents.Bioorg Med Chem Lett. 2025 Jul 1;122:130194. doi: 10.1016/j.bmcl.2025.130194. Epub 2025 Mar 22. Bioorg Med Chem Lett. 2025. PMID: 40122473
-
Antioxidant Serine-(NSAID) Hybrids with Anti-Inflammatory and Hypolipidemic Potency.Molecules. 2021 Jul 2;26(13):4060. doi: 10.3390/molecules26134060. Molecules. 2021. PMID: 34279399 Free PMC article.
-
Balancing Antioxidant, Hypolipidemic and Anti-inflammatory Activity in a Single Agent: The Example of 2-Hydroxy-2-Substituted Morpholine, 1,4-Benzoxazine and 1,4-Benzothiazine Derivatives as a Rational Therapeutic Approach against Atherosclerosis.Curr Med Chem. 2017;24(12):1214-1227. doi: 10.2174/0929867323666160814001803. Curr Med Chem. 2017. PMID: 27528055 Review.
-
Biological Properties, Health Benefits and Enzymatic Modifications of Dietary Methoxylated Derivatives of Cinnamic Acid.Foods. 2021 Jun 18;10(6):1417. doi: 10.3390/foods10061417. Foods. 2021. PMID: 34207377 Free PMC article. Review.
Cited by
-
A Review of Cinnamic Acid's Skeleton Modification: Features for Antibacterial-Agent-Guided Derivatives.Molecules. 2024 Aug 20;29(16):3929. doi: 10.3390/molecules29163929. Molecules. 2024. PMID: 39203007 Free PMC article. Review.
-
Cinnamyl Alcohol Attenuates Adipogenesis in 3T3-L1 Cells by Arresting the Cell Cycle.Int J Mol Sci. 2024 Jan 5;25(2):693. doi: 10.3390/ijms25020693. Int J Mol Sci. 2024. PMID: 38255766 Free PMC article.
-
Cinnamic Acid: A Shield Against High-Fat-Diet-Induced Liver Injury-Exploring Nrf2's Protective Mechanisms.Int J Mol Sci. 2025 Aug 17;26(16):7940. doi: 10.3390/ijms26167940. Int J Mol Sci. 2025. PMID: 40869259 Free PMC article.
-
Cinnamic acid alleviates endothelial dysfunction and oxidative stress by targeting PPARδ in obesity and diabetes.Chin Med. 2025 Jan 24;20(1):13. doi: 10.1186/s13020-025-01064-7. Chin Med. 2025. PMID: 39856769 Free PMC article.
-
Pediococcus pentosaceus JS35 improved flavor, metabolic profile of fermentation supernatant of mulberry leaf powder and increased its antioxidant capacity.Front Nutr. 2025 Mar 4;12:1551689. doi: 10.3389/fnut.2025.1551689. eCollection 2025. Front Nutr. 2025. PMID: 40104817 Free PMC article.
References
LinkOut - more resources
Full Text Sources